Canada markets close in 3 hours 38 minutes

GILD Jan 2025 32.500 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.07000.0000 (0.00%)
As of 11:20AM EDT. Market open.
Full screen
Previous Close0.0700
Open0.0600
Bid0.0400
Ask0.2400
Strike32.50
Expire Date2025-01-17
Day's Range0.0600 - 0.0700
Contract RangeN/A
Volume70
Open Interest210
  • Zacks

    Gilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat

    Gilead (GILD) reports narrower-than-expected loss in the first quarter. Its sales beat estimates on higher HIV, Oncology and Liver Disease sales.

  • Thomson Reuters StreetEvents

    Q1 2024 Gilead Sciences Inc Earnings Call

    Q1 2024 Gilead Sciences Inc Earnings Call

  • Business Wire

    FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV

    FOSTER CITY, Calif., April 26, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets, B/F/TAF) to treat pregnant people with HIV-1 (PWH) with suppressed viral loads. These additional data stem from Study 5310, which evaluated the pharmacokinetics, safety and efficacy of